Henry Schein Inc. (NASDAQ:HSIC) – Investment analysts at Northcoast Research reduced their Q2 2017 earnings per share estimates for shares of Henry Schein in a research note issued on Thursday. Northcoast Research analyst E. Snyder now anticipates that the brokerage will post earnings per share of $1.77 for the quarter, down from their previous estimate of $1.78. Northcoast Research also issued estimates for Henry Schein’s Q3 2017 earnings at $1.84 EPS, Q4 2017 earnings at $2.05 EPS and FY2017 earnings at $7.26 EPS.
A number of other research firms also recently weighed in on HSIC. Zacks Investment Research downgraded shares of Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, August 8th. Bank of America Corp. initiated coverage on shares of Henry Schein in a research note on Monday, September 12th. They set a “buy” rating and a $185.00 price target on the stock. Robert W. Baird reaffirmed an “outperform” rating and set a $176.00 price target (up previously from $175.00) on shares of Henry Schein in a research note on Tuesday, October 4th. Finally, Goldman Sachs Group Inc. raised shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price target on the stock in a research note on Tuesday, October 11th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and five have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $159.50.
Shares of Henry Schein (NASDAQ:HSIC) opened at 154.26 on Monday. Henry Schein has a 12 month low of $142.64 and a 12 month high of $183.00. The company has a 50-day moving average of $161.88 and a 200-day moving average of $169.89. The stock has a market capitalization of $12.62 billion, a PE ratio of 26.13 and a beta of 1.05.
Henry Schein (NASDAQ:HSIC) last issued its earnings results on Thursday, August 4th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.63 by $0.01. The firm earned $2.87 billion during the quarter, compared to the consensus estimate of $2.85 billion. Henry Schein had a net margin of 4.42% and a return on equity of 17.84%. The company’s revenue was up 9.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.46 earnings per share.
In related news, Director Paul Brons sold 3,381 shares of the firm’s stock in a transaction on Monday, August 29th. The shares were sold at an average price of $164.03, for a total transaction of $554,585.43. Following the completion of the sale, the director now directly owns 13,715 shares of the company’s stock, valued at approximately $2,249,671.45. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.27% of the company’s stock.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Zurich Insurance Group Ltd FI bought a new position in shares of Henry Schein during the first quarter valued at $3,204,000. National Pension Service raised its position in shares of Henry Schein by 4.4% in the first quarter. National Pension Service now owns 56,059 shares of the company’s stock valued at $9,677,000 after buying an additional 2,383 shares in the last quarter. AMP Capital Investors Ltd raised its position in shares of Henry Schein by 1.7% in the first quarter. AMP Capital Investors Ltd now owns 23,958 shares of the company’s stock valued at $4,141,000 after buying an additional 400 shares in the last quarter. Citizens Financial Group Inc RI raised its position in shares of Henry Schein by 1.0% in the first quarter. Citizens Financial Group Inc RI now owns 46,377 shares of the company’s stock valued at $8,006,000 after buying an additional 452 shares in the last quarter. Finally, Prudential PLC raised its position in shares of Henry Schein by 57.5% in the first quarter. Prudential PLC now owns 6,300 shares of the company’s stock valued at $1,088,000 after buying an additional 2,300 shares in the last quarter. 92.03% of the stock is owned by institutional investors.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.